Dataset Information


Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose.

ABSTRACT: The gut-derived hormone Fibroblast growth factor 19 (FGF19) could regulate glucose metabolism and is induced by bile acids (BAs) through activating Farnesoid X Receptor (FXR). FGF19 was found to decrease in subjects with isolated-impaired fasting glucose (I-IFG) and type 2 diabetes mellitus (T2DM). However, the reason for the change of FGF19 in subjects with different glucometabolic status remained unclear. Here we measured six BAs including chenodeoxycholic acid (CDCA), cholic acid, deoxycholic acid, their glycine conjugates and FGF19 levels during oral glucose tolerance test (OGTT) in normal glucose tolerance (NGT), isolated-impaired glucose tolerance, I-IFG, combined glucose intolerance (CGI) and T2DM subjects. After OGTT, serum FGF19 peaked at 120?min in all subjects. Glycine conjugated BAs peaked at 30?min, while free BAs did not elevated significantly. Consistent with the decrease trend in FGF19 levels, fasting serum CDCA levels in subjects with I-IFG, CGI and T2DM were significantly lower than NGT subjects (P?


PROVIDER: S-EPMC5519593 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3590488 | BioStudies
1000-01-01 | S-EPMC5816090 | BioStudies
2016-01-01 | S-EPMC5033570 | BioStudies
2012-01-01 | S-EPMC3506649 | BioStudies
2019-01-01 | S-EPMC6286408 | BioStudies
2017-01-01 | S-EPMC5341154 | BioStudies
2020-01-01 | S-EPMC7106714 | BioStudies
2013-01-01 | S-EPMC3790620 | BioStudies
2017-01-01 | S-EPMC5233735 | BioStudies
2020-01-01 | S-EPMC7230531 | BioStudies